1 Ocak 2019 Dergi makalesi Açık Erişim

Cetin Coban, Serap; Temel, Fehminaz; Duman, Pinar; Cosgun, Yasemin; Ozarslan, Fatma; Kayman, Tuba; Guven, Sirin; Bezirganoglu, Handan; Gunes, Omer; Yilmaz Ciftdogan, Dilek; Karadagli, Ese Eda; Kaya, Cemil; Kara, Ates

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Temel, Fehminaz</subfield>
    <subfield code="u">Gen Directorate Publ Hlth, Dept Hlth Threats Early Warning &amp; Response, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Duman, Pinar</subfield>
    <subfield code="u">Gen Directorate Publ Hlth, Dept Hlth Threats Early Warning &amp; Response, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Cosgun, Yasemin</subfield>
    <subfield code="u">Gen Directorate Publ Hlth, Dept Microbiol Reference Labs &amp; Biol Prod, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ozarslan, Fatma</subfield>
    <subfield code="u">Gen Directorate Publ Hlth, Dept Hlth Threats Early Warning &amp; Response, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kayman, Tuba</subfield>
    <subfield code="u">Gen Directorate Publ Hlth, Dept Hlth Threats Early Warning &amp; Response, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Guven, Sirin</subfield>
    <subfield code="u">Univ Hlth Sci, Istanbul Umraniye Training &amp; Res Hosp, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Bezirganoglu, Handan</subfield>
    <subfield code="u">Zekai Tahir Matern &amp; Child Hlth Hosp, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Gunes, Omer</subfield>
    <subfield code="u">Zekai Tahir Matern &amp; Child Hlth Hosp, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Yilmaz Ciftdogan, Dilek</subfield>
    <subfield code="u">Tepecik Educ &amp; Res Hosp, Izmir, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Karadagli, Ese Eda</subfield>
    <subfield code="u">Matern &amp; Child Hlth Hosp, Sanliurfa, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kaya, Cemil</subfield>
    <subfield code="u">Matern &amp; Child Hlth Hosp, Sanliurfa, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kara, Ates</subfield>
    <subfield code="u">Hacettepe Univ, Children Hosp, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">JAPANESE JOURNAL OF INFECTIOUS DISEASES</subfield>
    <subfield code="v">72</subfield>
    <subfield code="n">3</subfield>
    <subfield code="c">185-192</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.7883/yoken.JJID.2018.387</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Prevalence of Protective Measles Virus Antibody Levels in Umbilical Cord Blood Samples and Sera of Mothers and Transplacental Transport Ratio in Turkey</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Cetin Coban, Serap</subfield>
    <subfield code="u">Gen Directorate Publ Hlth, Dept Hlth Threats Early Warning &amp; Response, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:75901</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2019-01-01</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/75901/files/bib-82c816aa-53a6-44c9-84cc-fd62a9d10f8f.txt</subfield>
    <subfield code="z">md5:2d36b5a0b32c51d4222d12525c159dbd</subfield>
    <subfield code="s">391</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <controlfield tag="005">20210316043134.0</controlfield>
  <controlfield tag="001">75901</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">In Turkey, the Measles Elimination Program has been implemented since 2002. The aim of this study was to evaluate the measles-specific antibody levels of mothers admitted to a hospital for birth and their infants, to determine the factors influencing the antibody levels of both, and to evaluate the transplacental transport ratio. We selected healthy women who came to the hospital for birth and their healthy newborns. We collected blood samples from 1,547 mothers and 1,529 infants. The protective prevalence of measles antibody levels of mothers was 80% (95% confidence interval [CI]: 78-82%) and that of newborns was 85% (95% CI: 83-86%). The antibody levels of mothers and newborns were positively linearly correlated (R: 0.922, p &amp;lt; 0.001) and were associated with parity (p &amp;lt; 0.001). The ratio of neonatal to maternal antibody levels increased with gestational age. The protective levels were 1.6 times higher (95% CI: 1.1-2.4) in mothers &amp;gt;= 32 years of age and 2.1 times higher (95% CI: 1.4-3.3) in naturally immune mothers. Two factors affecting the antibody levels of newborns were the mothers' antibody levels and their immunization status. The antibody level of mother was the most significant factor that influenced the infant's antibody level. Vaccination of women before pregnancy could enhance passive antibody protection by increasing the level of transplacental transmission.</subfield>
  </datafield>
</record>